Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19

• A clinical worsening in CIDP may occur in concomitance with COVID-19. • Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism. • The management of these patients is particularly challenging.

Detalles Bibliográficos
Autores principales: Abu-Rumeileh, Samir, Garibashvili, Tamara, Ruf, Wolfgang, Fangerau, Tanja, Kassubek, Jan, Althaus, Katharina, Otto, Markus, Senel, Makbule
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Response to letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462872/
https://www.ncbi.nlm.nih.gov/pubmed/32911389
http://dx.doi.org/10.1016/j.jns.2020.117106
Descripción
Sumario:• A clinical worsening in CIDP may occur in concomitance with COVID-19. • Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism. • The management of these patients is particularly challenging.

Ejemplares similares